Teikoku Pharma bags FDA fast track for post-surgical transdermal analgesic
Pharmaceutical Technology
JUNE 21, 2023
The US Food and Drug Administration (FDA) has granted Teikoku Pharma’s dexmedetomidine transdermal system a fast track designation. It cites convenience, ease of administration, and the resulting improved patient compliance as advantages of its transdermal system.
Let's personalize your content